CD4 and anemia (phenotype): In this subgroup of patients, third-trimester anemia was associated with detectable VL at 34 weeks (p = 0.001), baseline and 34-week CD4+ cell counts (p = 0.002 and p = 0.003, respectively), and trimethoprim-sulfamethoxazole intake (p < 0.001).